Health care costs have been on the increase in the U.S. An extra $933 billion in 2013 was spent on health care compared to 1996. This has been attributed to the increase in charges on patients’ care. The growth in the general population, as well as aging, has increased health care spending.
Researchers are now focused on breaking down the spending by disease, and the different factors that lead to an increase in disease prevalence. Diabetes recorded the highest increase in annual health care spending. Most of the spending was on pharmaceuticals. Lower back pains, as well as neck pains, followed second in the list. The amount of money spent on taking care of these ailments increased per annum as much as the prevalence remained the same. An increase of 8.5% was recorded in inpatient care annually.
Annual spending on inpatient services increased from $258 billion to a whopping $697 billion. This was despite the efforts made to reduce that amount by $201 billion. The increase in spending was ironic since patients recorded shorter stays in hospitals. Spending went up even though hospitals provided all the necessary care in fewer days.
High drug prices have been justified by having to create savings through prevention of hospitalizations. This has not been convincing enough since health care spending keeps increasing.
Eric Lefkofsky is the CEO and co-founder of Tempus. The company’s focus is to come up with technological advancements to fight cancer. Eric Lefkofsky and his wife are renowned philanthropists to causes that are aimed at cancer research. Last year they donated about $3 million to various research institutes that are aimed towards fighting cancer.
Eric Lefkofsky founded the Lefkofsky Family Foundation in 2006. This charitable foundation aims at positively impacting the lives of the communities that they serve. He serves at the Lurie Children’s Hospital of Chicago, The Museum of Science and Industry, The Art Institute of Chicago, and the World Business Chicago as a Trustee. Lefkofsky also serves as a professor at the University of Chicago. He is also a writer, he authored the book Accelerated Disruption. Lefkofsky studied at the University of Michigan’s school of law and got his Juris Doctor.
Since Oncotarget was first published in the oncology industry, it has been able to help many different people. Those who are looking at the different things that can happen with cancer are getting a lot of the information that they can from the publication. The Oncotarget publication was created by an oncologist and he worked hard to make sure that he was including other people who were able to have a more positive experience while trying to treat cancer. This is something that was important for the creator and something that he knew he would be able to do while he was trying different things. He also knew that his experience would pay off so that he could help different patients with the treatment that they needed. For Oncotarget to be able to make things better, the publication had to continue to operate and there needed to be different options that people had.
Now that there are more than just oncologists who are a part of the publication, it is helping even more people. Oncologists are learning things about what they can do to make things better for their own practices. Many of them even just recently found out that they can use anti-aging treatments to help with cancer treatment. This is something that most people did not know about before and it is something that other people have tried to figure out so that they can do more with the other opportunities that they have.
Since Oncotarget is now operating properly and people are seeing all of the benefits that come from it, it is going to help people with all of the issues that they are having. Oncotarget is a publication that is dedicated to medical research and there have been many things that have helped Oncotarget to grow. The doctors that work together and share ideas on the peer review publication are able to help each other out. The publication has been instrumental in making things better for people who are trying to fight cancer and for people who are trying to fight some of the other diseases.
To know more click here
Cancer diseases have been a major reason behind the increase in national mortality rate for so long. For most people, a cancer diagnosis means putting one’s affairs in order and waiting for death to catch up with them but that is not the case anymore. Rutgers Cancer Institute of New Jersey is the new sense of hope for many of the cancer patients in the world. The institute is the only designated comprehensive cancer institute in the whole state. According to Yahoo.com, it is also a research facility that is geared towards better diagnosis, treatment and care of cancer patients. They translate the research carried out in their laboratories and use it in their clinical practice to come up with better ways of treatment. The hospital works closely with other cancer treatment centers and research facilities in order to ensure that it covers a wider range of patients in their research. This has further been made possible by the most recent pledge from Omar Boraie’s family.
The cancer institute came up with an idea to gain endorsement on their projects where they have eighteen chairs heading their research facilities that are in turn supported financially by the anonymous donors providing a matching donation of $1.5 million. According to the article on Newswise, Omar Boraie’s family made such a donation to the recently established Omar Boraie chair. The money will go into the research of genetic treatment of cancer. The treatment will target the precise treatment of cancer where it will give an individualistic approach to the method of treatment. The study will eventually categorize cancers according to sub-groups of people with different genes but similar characteristics.
According to the Wall Street Journal, the institution’s doctor Shridar Ganesan who also works as associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School has been named the chair. He describes cancer as a set of diseases rather than a single disease. He says that this method of treatment will study cancers according to their unique symptoms hence people can get individualistic diagnosis and therapy. To Boraie, this is hope for all the people in the world with unique cancers and those whose cancer has become unresponsive to various forms of treatment or have limited treatment options. Boraie hopes that this will bring change in the world so people will no longer succumb to cancer. It will also open the door to research on treatment of other similar diseases that could display uniqueness from one person to the other.
Read More: http://www.nytimes.com/2005/03/06/realestate/at-two-extremes-of-a-housing-market.html